Digital Poster Gallery
Please search the digital poster gallery to explore the most innovative approaches to fighting AMR.
AID Diagnostika GmbH
Novel ESBL Assay closes the gap for fast and reliable detection of most important ESBL genes
Allecra Therapeutics
Preclinical safety evaluation following prolonged (3 months) administration of a combination ofenmetazobactam and cefepime in Beagle dogs
Allecra Therapeutics
Human mass balance study of Enmetazobactam using 14C analysed by AMS
Amprologix
Epidermicins – a new family of antimicrobial proteins with excellent clinical potential
Aphanosos
Differential robustness as a system’s biology target enables innovative antimicrobials overcoming at least many known resistance mechanisms
ATG:biosynthetics GmbH
AM Vaccination:
PepID – Bioinformatics for the Development of Immune Diagnostics and Vaccines: Combining Comparative Genomics and Computational Analyses of Pathogen Genomes with High Density Peptide Micro Arrays (HDPMA) and Expressed Epitope – Imophores
BioVersys AG
Inhibition of AgrA-mediated virulence factor expression in MRSA: a viable, non-lethal, treatment option.
Clemedi AG
Tuberculini: combining targeted sequencing and machine learning to optimize antibiotic therapy in tuberculosis patients
ETH Zürich, D-BSSE
Massively parallelized growth assays (MeX) for discovery of antimicrobial peptides
FluoretiQ Ltd
Glycan functionalisation of latex nanoparticles for detection of Uropathogenic Escherichia coli (UPEC) species
Fraunhofer ITEM
Pseudomonas aeruginosa flagellin and UGP determine bacterial virulence and host immune response in an ex vivo model of lung infection
Fraunhofer ITEM
Impact of aging on host immune responses to different Pseudomonas aeruginosa strains
Fundación MEDINA
IIMENA: Integrating informatics and metabolic engineering for the biosynthesis of novel antibiotics.
Helmholtz-Institute for Pharmaceutical Research Saarland (HIPS)
Towards preclinical development of amidochelocardin, a bioengineered broad-spectrum antibiotic for treatment of complicated urinary tract infection (cUTI)
HYpharm GmbH
Pre-clinical development of HY-133, a bacteriophage derived drug for the specific eradication of S. aureus in the nose
InfectoGnostics Research Campus Jena / Friedrich-Schiller-University Jena
Photonics-based Concepts in Antimicrobial susceptibility testing (AST) – an Update
InfectoGnostics Research Campus Jena / Friedrich-Schiller-University Jena
Discrimination between ESBL and CRE strains using UV-Resonance Raman spectroscopy
InfectoGnostics Research Campus Jena / Leibniz-IPHT Jena
Characterisation of a poorly known S. aureus / MRSA lineage from the Middle East
InfectoGnostics Research Campus Jena / Leibniz-IPHT Jena
Elucidation of emergence, dissemination and global transmission of multidrug-resistant strains using sequencing data
International Institute of Molecular and Cell Biology in Warsaw, Poland
BACTERIOLYTIC ENZYME AURESINE a new, selective weapon against Staphylococcus
Panjab University
Roseocin: A novel antimicrobial against antibiotic resistant pathogens
Resistomap
Resistomap: a complete service to monitor antibiotic resistance genes in the environment
The Pew Charitable Trusts
The Shared Platform for Antibiotic Research and Knowledge: SPARKing Innovation in Gram-Negative Antibiotic Discovery
The Pew Charitable Trusts
Evaluation of the Global Clinical Pipeline of Antibiotics and Nontraditional Bacterial Products
University Hospital Bonn
Pre-clinical development of Corallopyronin A – a novel natural product active against helminths, STIs and Staphylococci
University Hospital Cologne
Rapid detection of OXA-23-, OXA-40- and OXA-58-mediated carbapenem resistance in Acinetobacter baumannii
University of Cagliari
A step towards the prediction of molecules accumulation in Gram negative bacteria
University of Tromsø – The Arctic University of Norway
Nano-antimicrobials in biofilm eradication
University of Tuebingen- Interfaculty Institute of Microbiology and Infection Medicine (IMIT)
Development of a Small Molecule Inhibitor of Salmonella Invasion-related Pathogenicity